Castle Biosciences Inc (CSTL)
29.81
+0.93
(+3.22%)
USD |
NASDAQ |
Nov 22, 16:00
29.81
0.00 (0.00%)
After-Hours: 20:00
Castle Biosciences Profit Margin (Quarterly): 2.65% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 2.65% |
June 30, 2024 | 10.25% |
March 31, 2024 | -3.47% |
December 31, 2023 | -3.90% |
September 30, 2023 | -11.23% |
June 30, 2023 | -37.45% |
March 31, 2023 | -69.47% |
December 31, 2022 | -53.78% |
September 30, 2022 | -54.71% |
June 30, 2022 | -4.73% |
March 31, 2022 | -91.70% |
December 31, 2021 | -25.68% |
September 30, 2021 | -50.23% |
June 30, 2021 | -38.63% |
Date | Value |
---|---|
March 31, 2021 | -18.76% |
December 31, 2020 | -28.26% |
September 30, 2020 | -30.16% |
June 30, 2020 | -10.82% |
March 31, 2020 | 3.27% |
December 31, 2019 | 11.65% |
September 30, 2019 | 39.59% |
June 30, 2019 | -11.82% |
March 31, 2019 | -15.58% |
December 31, 2018 | 33.83% |
September 30, 2018 | -92.95% |
June 30, 2018 | -79.28% |
March 31, 2018 | -99.23% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-91.70%
Minimum
Mar 2022
11.65%
Maximum
Dec 2019
-25.26%
Average
-22.22%
Median
Profit Margin (Quarterly) Benchmarks
Delcath Systems Inc | 16.64% |
Star Equity Holdings Inc | -14.42% |
Exact Sciences Corp | -5.40% |
CytoSorbents Corp | -27.10% |
Progyny Inc | 3.64% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | 1.49% |
Return on Assets | 1.29% |
Return on Invested Capital | 1.46% |
Gross Profit Margin (Quarterly) | 81.80% |
Operating Margin (Quarterly) | 5.92% |
Return on Net Operating Assets | 2.90% |